Full Stack
Rigetti Computing
Overview
Rigetti Computing is a full-stack superconducting quantum computing company that designs, fabricates, and operates its own quantum processors, offering cloud-based quantum computing access through its Quantum Cloud Services (QCS) platform. Founded in 2013 by Chad Rigetti, a former IBM quantum researcher, the company occupies a distinctive position in the sector as one of the few quantum hardware firms that operates its own dedicated semiconductor fabrication facility — Fab-1, located in Fremont, California. This vertical integration is central to Rigetti's thesis: that controlling the full hardware stack from chip design through cloud delivery enables faster iteration cycles and tighter performance optimization than outsourcing fabrication to third-party foundries.
Rigetti's commercial strategy targets near-term quantum advantage in hybrid classical-quantum workloads, particularly optimization, simulation, and machine learning applications. The company sells compute access to enterprises, national labs, and government agencies through QCS, and has secured a series of contracts with agencies including DARPA, NASA, and the Air Force Research Laboratory. Its Novera QPU — a 9-qubit system released in late 2023 as an on-premises product — represents its entry into the private deployment market, targeting research institutions that require local quantum hardware. The company's flagship cloud-accessible processors have scaled to 84 qubits (the Ankaa-series), with higher-qubit systems on the roadmap.
In the competitive landscape, Rigetti sits between IBM and Google on one side — better-resourced incumbents with larger qubit counts and more mature error correction programs — and smaller or earlier-stage hardware startups on the other. Its most direct competitors in superconducting quantum computing are IBM, Google, and IQM. Rigetti differentiates primarily through its fab ownership, its QCS platform's developer ecosystem, and its willingness to sell on-premises hardware — a capability IBM also offers but fewer others do. However, Rigetti faces persistent pressure on both qubit performance metrics and financial resources relative to the hyperscalers and well-capitalized private competitors.
The September 2026 finalization of a $100 million CHIPS Act award from the U.S. Department of Commerce — part of a coordinated $300 million allocation split equally among D-Wave, Rigetti, and Quantinuum — materially changes Rigetti's near-term financial position and represents explicit federal validation of its superconducting roadmap. The government takes a minority equity stake as part of the arrangement. Combined with earlier inclusion in the Trump administration's June 2026 executive orders naming Rigetti as a beneficiary of the national quantum initiative, the company now has substantial non-dilutive capital and policy tailwinds that were absent from its balance sheet a year prior.
Leadership
Previously served as CEO of CML Microsystems and held senior leadership roles at Cypress Semiconductor and Marvell Technology, bringing deep semiconductor operations and commercialization experience to a hardware-centric quantum company.
Joined Rigetti with an operational and engineering background, overseeing manufacturing, supply chain, and day-to-day business operations including Fab-1 activities.
Brings public company financial management experience relevant to Rigetti's NASDAQ-listed status and ongoing capital markets activity.
Research leadership focused on quantum algorithm development, compilers, and near-term applications, with prior work at Los Alamos National Laboratory.
Technology
Rigetti builds superconducting transmon qubit processors using a proprietary multi-chip module (MCM) architecture that it calls 'Ankaa.' The MCM approach allows individual chiplets to be fabricated and tested separately before being assembled into a larger processor, which Rigetti argues improves yield and scalability compared to monolithic chip designs. All fabrication occurs at Fab-1, Rigetti's in-house facility, giving the company control over process parameters — including Josephson junction deposition and qubit geometry — that are critical to coherence times and gate fidelities. The $100 million CHIPS Act award announced in September 2026 is specifically structured to fund engineering work on miniaturizing high-density readout and control electronics, which represents one of the primary physical bottlenecks to scaling superconducting systems beyond a few hundred qubits.
Rigetti's current flagship processor, the Ankaa-2, features 84 qubits arranged in a square lattice topology with tunable couplers that enable faster two-qubit gates compared to fixed-frequency architectures. The company has reported two-qubit gate fidelities in the range of approximately 97–98% on Ankaa-2, though these figures represent median performance across the device and vary by qubit pair — a distinction that matters for circuit depth at scale. Coherence times (T1, T2) on recent Rigetti chips are in the range of tens to low hundreds of microseconds, broadly competitive with industry peers though IBM and Google have reported higher figures on select devices. Rigetti also publishes a metric called Algorithmic Qubit (AQ) count, which captures the number of qubits that can be reliably used in a given circuit depth — a more application-relevant measure than raw qubit count.
The QCS platform provides low-latency cloud access to Rigetti's processors, and the company has emphasized its ability to offer dedicated access rather than shared queue-based access — a meaningful differentiator for enterprise and government customers with reproducibility requirements. Pyquil, Rigetti's open-source quantum programming library, underpins developer access and maintains a modest but active user community. The September 2026 publication of a qubit-efficient optimization algorithm validated on Rigetti hardware demonstrates continued internal research output, though the broader algorithmic community has tended to benchmark preferentially on IBM's larger and more documented devices.
Key Systems
- Ankaa-2 (84-qubit superconducting processor, cloud-accessible via QCS)
- Novera QPU (9-qubit on-premises system, released late 2023)
- Quantum Cloud Services (QCS) platform
- Fab-1 (proprietary superconducting chip fabrication facility, Fremont, CA)
Performance Highlights
- Ankaa-2: 84 qubits with tunable couplers, median two-qubit gate fidelity approximately 97–98% (as reported by Rigetti; independently unverified figures)
- Multi-chip module (MCM) architecture enabling modular scaling beyond monolithic chip yield limits
- Algorithmic Qubit (AQ) metric introduced as application-relevant performance benchmark
- Novera QPU: first commercially available on-premises Rigetti system, 9 qubits, targeting research lab deployments
- $100M CHIPS Act funding structured specifically around readout miniaturization — a recognized hardware scaling bottleneck
Financials
Rigetti went public via SPAC merger with Supernova Partners Acquisition Company in March 2022, listing on NASDAQ under the ticker RGTI. The SPAC process raised approximately $261 million in gross proceeds, but the company subsequently faced the same post-SPAC market correction that hit most quantum computing names: the stock declined sharply from its initial trading levels, reflecting broader repricing of pre-revenue deep tech companies. Revenue has been modest and largely contract-driven — the company reported approximately $12–14 million in annual revenue for FY2024 (figures are approximate; exact FY2025 audited results were not available at time of writing), derived from QCS cloud access, government research contracts, and licensing. This revenue base is insufficient to approach breakeven given the company's operating cost structure.
Prior to the September 2026 CHIPS Act award, Rigetti's balance sheet was a persistent concern for investors. The company has required periodic equity raises to fund operations, and burn rate has been estimated in the range of $15–20 million per quarter, implying a runway measured in quarters rather than years absent new capital. The $100 million CHIPS Act award — structured as non-dilutive government funding in exchange for a minority equity stake held by the Commerce Department rather than through open-market share issuance — materially extends this runway and reduces near-term capital markets execution risk. The government equity stake does introduce a new structural consideration for future M&A scenarios.
Market capitalization has been highly volatile and sentiment-driven, with RGTI subject to significant retail and options trading activity. The stock has at various points traded at multiples of revenue exceeding 30–50x, reflecting speculative positioning on long-term quantum adoption rather than near-term fundamentals. Post-CHIPS Act announcement, shares moved approximately 5–7% in premarket trading, consistent with the market's read of the award as a meaningful but not transformative catalyst. Investors should note that the company's long-term financial sustainability remains contingent on either achieving commercial revenue scale or continuing to secure government and institutional capital.
Key Figures
- Approximately $12–14M estimated annual revenue FY2024 (exact FY2025 figures pending)
- $100M CHIPS Act award finalized September 2026, non-dilutive, government takes minority equity stake
- Included in U.S. government's $2B quantum commitment announced June 2026 (up to $100M proposed per company)
- SPAC IPO March 2022, approximately $261M gross proceeds
- Estimated quarterly cash burn approximately $15–20M (approximate, based on prior public filings)
Milestones
Most significant single capital event since SPAC IPO; materially extends runway, provides non-dilutive funding, and represents explicit federal validation of Rigetti's superconducting roadmap. Sets precedent for direct government equity in public quantum hardware companies.
Policy-level endorsement at presidential order level, with direct procurement and funding implications. Signals Rigetti is viewed as a near-term deliverable platform by the current administration.
Part of a broad federal investment wave; confirms Rigetti's position in the top tier of U.S.-backed quantum hardware companies, though the field has expanded and competition for government dollars is intensifying.
Demonstrates continued internal research productivity and near-term algorithmic relevance; hardware-validated results are more credible than simulation claims, though commercial application impact remains to be demonstrated.
First Rigetti product targeting private on-premises deployment; opens a new revenue channel distinct from cloud access, and positions Rigetti alongside IBM in the growing market for lab-deployable quantum hardware.
Represents Rigetti's most capable hardware generation; tunable couplers enable faster two-qubit gates and MCM architecture is the company's primary technical bet for scalability beyond current qubit counts.
Government contracts have been the primary revenue stabilizer; demonstrates that Rigetti's hardware is being used in federally funded research contexts even absent large-scale commercial enterprise adoption.
Provided approximately $261M in capital and public company status; subsequent stock decline reflected broader de-rating of quantum computing equities but also Rigetti-specific concerns about revenue trajectory and competitive positioning.
Roadmap
Rigetti's publicly stated roadmap targets continued scaling of its superconducting qubit count through the MCM architecture, with a stated goal of reaching hundreds of qubits in logically useful configurations. The company has referenced targets in the range of 336 qubits and beyond, though specific timeline commitments have historically been revised — Rigetti, like most quantum hardware companies, has experienced roadmap slippage relative to its earliest public projections. The $100 million CHIPS Act award, structured around readout miniaturization and high-density control electronics, directly addresses one of the practical engineering constraints on scaling: the wiring and cryogenic overhead required to read out large numbers of qubits simultaneously without thermal loading or signal crosstalk.
On error correction, Rigetti's current systems operate in the NISQ (Noisy Intermediate-Scale Quantum) regime, and the company has not publicly demonstrated logical qubit operations comparable to those shown by IBM, Google, or Quantinuum. The roadmap envisions improving gate fidelities and coherence times as prerequisites to implementing surface code error correction at scale, but Rigetti has been less specific than IBM or Google about concrete fault-tolerant milestones and timelines. This is a meaningful gap relative to competitors who have published peer-reviewed QEC results. The Trump administration's executive order mandate for a 'powerful quantum computer by 2028' — with Rigetti named as a beneficiary — implies federal pressure for near-term demonstrable capability, which may accelerate internal prioritization of algorithm-relevant benchmarks over longer-term fault-tolerance research.
Commercially, Rigetti's roadmap emphasizes expanding QCS access, growing the Novera QPU on-premises product line, and developing hybrid classical-quantum software tools to lower the barrier for enterprise adoption. The company has indicated interest in scaling its Novera line to higher qubit counts for on-premises deployment, which would directly compete with IBM's System One and emerging offerings from IQM. Timeline confidence is moderate at best: Rigetti has demonstrated consistent hardware iteration but has not yet achieved the kind of step-change performance milestone — such as a verified quantum advantage demonstration or a break-even logical qubit — that would reframe its competitive position.
Competitive Position
Rigetti's most direct superconducting competitors are IBM Quantum, Google Quantum AI, and IQM — all of which have larger R&D budgets and, in IBM and Google's case, significantly more advanced qubit counts and published error correction results. IBM's 1,000+ qubit Condor and Heron processors, and Google's recent quantum advantage claims, set benchmarks that Rigetti's 84-qubit Ankaa-2 does not yet approach in raw scale. However, raw qubit count is not the sole commercial differentiator: Rigetti's fab ownership, QCS platform, Novera on-premises product, and now CHIPS Act-backed funding position it as a U.S.-sovereign superconducting hardware provider at a moment when supply chain security and domestic manufacturing are explicit federal priorities. IQM, headquartered in Finland, cannot make the same domestic manufacturing claim for U.S. government procurement.
Beyond superconducting, Rigetti competes for the same enterprise and government compute budgets as trapped-ion leaders Quantinuum and IonQ, neutral-atom companies like Atom Computing and QuEra, and photonic players like PsiQuantum. Quantinuum's July 2026 demonstration of a universal topological gate set — a landmark result published in Nature — and Microsoft/Quantinuum's QEC results in Nature represent the kind of peer-reviewed scientific milestones that shift investor and government perception of which platforms are on the fault-tolerance frontier. Rigetti has not published equivalent results, which is a meaningful credibility gap in the current environment where scientific publication in high-impact journals is increasingly used as a proxy for technical seriousness.
Rigetti's defensible advantages are limited but real: fab ownership enables rapid process iteration that fabless competitors cannot match; the QCS platform has a multi-year developer head start over newer entrants; and the CHIPS Act award, alongside the government equity stake, creates institutional alignment with federal procurement that could generate preferred vendor status in national security contexts. Its primary vulnerability is the gap between its hardware performance metrics and those of the leading superconducting and trapped-ion players — a gap that, if it widens rather than narrows, would undermine both commercial and government contract competitiveness regardless of balance sheet improvements.
Risks & Opportunities
Key Risks
- Hardware performance gap: Rigetti's current qubit counts (84 qubits, Ankaa-2) and published fidelities trail IBM and Google; failure to close this gap through the MCM scaling roadmap would erode competitive position for both government and enterprise contracts.
- No verified quantum advantage: Unlike IBM (July 2026 coalition claim) and Quantinuum (topological gate set, Nature 2026), Rigetti has not published a peer-reviewed milestone that reframes its technical standing — absence of such results in a publication-competitive environment is a credibility risk.
- Revenue concentration and scale: Revenue remains heavily dependent on government contracts and modest QCS cloud usage; failure to achieve commercial enterprise revenue growth at scale keeps the company in a structurally loss-making position even with CHIPS Act capital.
- Government equity stake creates M&A complexity: The Commerce Department minority stake acquired as part of the CHIPS Act deal introduces regulatory considerations and potential restrictions on future acquisition scenarios, limiting exit optionality for existing shareholders.
- Fab-1 operational risk: Operating a proprietary semiconductor fab is capital-intensive and operationally complex; yield challenges, equipment failures, or talent attrition in the fab team would directly impair hardware output and roadmap execution.
- Competitive capital disparity: IBM and Google are deploying quantum R&D budgets orders of magnitude larger than Rigetti's total capitalization; even with CHIPS Act funding, Rigetti cannot match the R&D throughput of these incumbents over multi-year horizons.
- CHIPS Act funding conditionality: Government awards of this type typically carry milestone-based disbursement schedules and reporting requirements; failure to meet engineering milestones could result in funding delays or clawbacks.
Key Opportunities
- $100M CHIPS Act award with readout miniaturization focus: If Rigetti successfully executes on the funded engineering programs, it could achieve a step-change in scalability that closes the qubit count gap with leading competitors, funded by non-dilutive capital.
- U.S. sovereign quantum manufacturing premium: Federal procurement increasingly favors domestic suppliers; Rigetti's U.S.-based fab is a structural advantage for classified and sensitive government contracts that foreign-headquartered or fabless competitors cannot access.
- Novera QPU on-premises market expansion: The private on-premises quantum hardware market is nascent; scaling the Novera line to higher qubit counts could capture research institution and national lab deployments before competing on-premises products mature.
- Trump administration 2028 quantum mandate: Named as a beneficiary in presidential executive orders with a 2028 deliverable deadline, Rigetti is positioned to receive prioritized federal contract and procurement flow if it can demonstrate milestones aligned with that timeline.
- Hybrid algorithm commercialization: Near-term quantum advantage in constrained optimization, quantum chemistry, or machine learning hybrid workflows remains commercially plausible before full fault tolerance; Rigetti's qubit-efficient algorithm research (September 2026) is directionally relevant to this opportunity.
- Ecosystem consolidation: As the quantum sector matures, well-capitalized players or strategic acquirers (defense primes, semiconductor companies, hyperscalers) may pursue acquisitions; Rigetti's fab ownership and QCS platform make it a strategically differentiated acquisition target despite its scale.
Investment Considerations
The bull case for RGTI rests on a convergence of policy tailwinds, strategic asset ownership, and improved capital position. The $100 million CHIPS Act award, finalized in September 2026 alongside D-Wave and Quantinuum, is not merely incremental funding — it represents explicit U.S. government conviction that Rigetti's superconducting platform is worth backing at national scale, and the non-dilutive structure preserves existing shareholder value better than equity raises would. Rigetti's fab ownership is an underappreciated strategic asset: in a world where semiconductor supply chain sovereignty is a federal priority, a U.S.-domiciled quantum chip fab with proprietary process knowledge is difficult to replicate quickly. If the MCM architecture delivers on its scaling thesis and Rigetti can demonstrate hardware parity or advantage in specific algorithmic domains — particularly those targeted by the 2028 executive order mandate — the company could transition from a speculative NISQ-era player to a federally anchored quantum hardware supplier with recurring contract revenue. At current revenue multiples, even modest commercial traction would represent significant upside.
The bear case is equally substantive. Rigetti has been a public company since 2022 and has not yet demonstrated the kind of scientific or commercial milestone — a peer-reviewed quantum advantage claim, a logical qubit demonstration, a large enterprise contract — that would justify sustained premium valuation. IBM, Google, and Quantinuum are all publishing in Nature while Rigetti's most recent notable research output is a qubit-efficient optimization algorithm of incremental rather than landmark significance. The company burns cash faster than it generates revenue, and while the CHIPS Act award extends runway, it does not solve the structural revenue problem. Government equity stakes can complicate future strategic transactions. Perhaps most importantly, Rigetti is competing in a sector where the two largest technology companies in the world (IBM and Google) are active hardware developers — a competitive dynamic that has historically been very difficult for smaller players to navigate, regardless of fab ownership or policy support. Investors should size positions accordingly and monitor hardware performance benchmarks and peer-reviewed publication output as the most reliable leading indicators of competitive trajectory.
Recent Digest Coverage
- 2026-09-14 Rigetti secures $100M CHIPS Act award from Commerce Department ↗
- 2026-09-14 Rigetti's $100M CHIPS Act contract details: readout miniaturization focus ↗
- 2026-09-10 PsiQuantum wins $100M federal award for photonic chip scaling. ↗
- 2026-09-10 $300M CHIPS Act split among D-Wave, Rigetti, Quantinuum. ↗
- 2026-09-08 D-Wave, Rigetti, Quantinuum each land $100M CHIPS Act deals ↗